Cargando…
Rapid Progress in Immunotherapies for Multiple Myeloma: An Updated Comprehensive Review
SIMPLE SUMMARY: Despite rapid advances in the development of novel agents over the last decade for the treatment of multiple myeloma (MM), MM remains an incurable disease. Therefore, the development of novel targeting therapies with different mechanisms of action is needed to achieve a deep and dura...
Autor principal: | |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8198014/ https://www.ncbi.nlm.nih.gov/pubmed/34072645 http://dx.doi.org/10.3390/cancers13112712 |